NASDAQ: MTEX
Mannatech Inc Stock

$9.70+0.23 (+2.43%)
Updated Apr 22, 2025
MTEX Price
$9.70
Fair Value Price
$13.49
Market Cap
$18.44M
52 Week Low
$6.75
52 Week High
$16.49
P/E
7.35x
P/B
2.14x
P/S
0.22x
PEG
N/A
Dividend Yield
N/A
Revenue
$117.87M
Earnings
$2.49M
Gross Margin
77.6%
Operating Margin
3.41%
Profit Margin
2.1%
Debt to Equity
3.19
Operating Cash Flow
$2M
Beta
0.28
Next Earnings
Jun 11, 2025
Ex-Dividend
N/A
Next Dividend
N/A

MTEX Overview

Mannatech, Incorporated operates as a health and wellness company worldwide. It develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management products. The company primarily sells its products directly, as well as through e-commerce and network marketing channels. Mannatech, Incorporated was founded in 1993 and is headquartered in Flower Mound, Texas.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine MTEX's potential to beat the market

Zen Rating Component Grades

N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Household & Personal Product

Industry Rating
C
MTEX
Ranked
Unranked of 25

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$25.35B
$4.08C
$65.43C
View Top Household & Personal Product Stocks

Be the first to know about important MTEX news, forecast changes, insider trades & much more!

Overview

Due Diligence Score

Industry Average (33)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how MTEX scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

MTEX ($9.70) is undervalued by 28.07% relative to our estimate of its Fair Value price of $13.49 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
MTEX ($9.70) is significantly undervalued by 28.07% relative to our estimate of its Fair Value price of $13.49 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
MTEX was unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more MTEX due diligence checks available for Premium users.

Valuation

MTEX fair value

Fair Value of MTEX stock based on Discounted Cash Flow (DCF)

Price
$9.70
Fair Value
$13.49
Undervalued by
28.07%
MTEX ($9.70) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
MTEX ($9.70) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
MTEX was unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

MTEX price to earnings (PE)

For valuing profitable companies with steady earnings

Company
7.35x
Industry
26.2x
Market
28.14x
MTEX is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
MTEX is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

MTEX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
2.14x
Industry
7.56x
MTEX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

MTEX's financial health

Profit margin

Revenue
$29.0M
Net Income
$2.3M
Profit Margin
7.8%
MTEX's Earnings (EBIT) of $4.02M... subscribe to Premium to read more.
Interest Coverage Financials
MTEX's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$36.1M
Liabilities
$27.4M
Debt to equity
3.19
MTEX's short-term assets ($26.12M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MTEX's short-term assets ($26.12M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MTEX's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
MTEX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$219.0k
Investing
$118.0k
Financing
-$905.0k
MTEX's operating cash flow ($2.26M)... subscribe to Premium to read more.
Debt Coverage Financials

MTEX vs Household & Personal Product Stocks

TickerZen RatingMarket Cap1d %P/EP/B
MTEX$18.44M+2.39%7.35x2.14x
BSLK$9.13M+4.53%-0.06x-1.06x
TANHC$415.10k+5.29%0.04x0.00x
UG$38.82M-1.00%11.90x3.27x
GROVC$42.16M0.00%-1.38x-4.93x

Mannatech Stock FAQ

What is Mannatech's quote symbol?

(NASDAQ: MTEX) Mannatech trades on the NASDAQ under the ticker symbol MTEX. Mannatech stock quotes can also be displayed as NASDAQ: MTEX.

If you're new to stock investing, here's how to buy Mannatech stock.

What is the 52 week high and low for Mannatech (NASDAQ: MTEX)?

(NASDAQ: MTEX) Mannatech's 52-week high was $16.49, and its 52-week low was $6.75. It is currently -41.18% from its 52-week high and 43.7% from its 52-week low.

How much is Mannatech stock worth today?

(NASDAQ: MTEX) Mannatech currently has 1,900,930 outstanding shares. With Mannatech stock trading at $9.70 per share, the total value of Mannatech stock (market capitalization) is $18.44M.

Mannatech stock was originally listed at a price of $225.00 in Feb 16, 1999. If you had invested in Mannatech stock at $225.00, your return over the last 26 years would have been -95.69%, for an annualized return of -11.39% (not including any dividends or dividend reinvestments).

How much is Mannatech's stock price per share?

(NASDAQ: MTEX) Mannatech stock price per share is $9.70 today (as of Apr 22, 2025).

What is Mannatech's Market Cap?

(NASDAQ: MTEX) Mannatech's market cap is $18.44M, as of Apr 23, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Mannatech's market cap is calculated by multiplying MTEX's current stock price of $9.70 by MTEX's total outstanding shares of 1,900,930.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.